Gökkaya, İçimYazıcı, NurdanSeyhan, GökçeÇakır, OğuzYılmaz, Mustafa AbdullahBarut, BurakRenda, Gülin2024-08-162024-08-162024Gökkaya, İ., Yazıcı, N., Seyhan, G., Çakır, O., Yılamz, M. A., Barut, B. ve diğerleri. (2024). Evaluation of Hedera species as herbal medicine raw materials. Natural Product Research, 1-8.1478-6419https://www.tandfonline.com/doi/full/10.1080/14786419.2024.2370044https://hdl.handle.net/11468/28750This study aimed to evaluate the potential of Hedera colchica as an alternative to Hedera helix species for the treatment of mild inflammatory conditions of the upper respiratory tract and chronic inflammatory bronchial diseases. The H. colchica extract with the highest saponin content (C3S; 468.19 ± 16.01 mg HE/g dry weight) and the extract with the highest total phenol content (C1F; 108.60 ± 5.61 mg GAE/g dry weight). Chemical analysis and standardisation of the extract with the highest selective COX-2 inhibitory effect was performed using the LC-MS/MS technique. It was determined that the substances found in the highest ratio in the C1F extract were quinic acid (45.909 µg/g extract) and hesperidin (37.077 µg/g extract). As a result, secondary metabolites, in addition to saponins, found in Hedera species may also contribute to the extract’s effectiveness, more potent extracts can be obtained compared to the total extract-containing preparations available in the market.eninfo:eu-repo/semantics/openAccessAnti-inflammatoryHederaLC-MS/MSMedicinal productStandardisationArticle18WOS:0012603124000012-s2.0-8519760898438949574Q1N/A